搜索临床试验以:Substrate Partitioning
总计324个结果
-
Epizyme, Inc.完全的套细胞淋巴瘤 | 边缘区淋巴瘤 | 晚期实体瘤 | 弥漫性大 B 细胞淋巴瘤 | 原发性纵隔淋巴瘤美国
-
Clinical Nutrition Research Centre, SingaporeAgency for Science, Technology and Research完全的
-
Maria Sklodowska-Curie National Research Institute...完全的
-
Hospital Clinic of BarcelonaGregorio Marañón Hospital完全的
-
Pacific Rim Electrophysiology Research InstituteUniversity Hospital, Bordeaux; Taipei Veterans General Hospital, Taiwan; Indiana University; University... 和其他合作者完全的
-
Takeda完全的癌,晚期 ALK+ 或 ROS1+ 非小细胞肺,肿瘤,晚期 ALK+ 或 ROS1+ 实体瘤西班牙, 意大利, 荷兰, 法国
-
Fundacion para la Innovacion en Biomedicina (FIBMED)Biosense Webster, Inc.主动,不招人
-
Emalex Biosciences Inc.ICON Early Phase Services; Nuventra完全的
-
University Hospital OstravaUniversity of Ostrava; Hospital Podlesi; Hospital Novy Jicin完全的
-
R-Pharm International, LLCIQVIA RDS Ireland Ltd; Thermo Fisher Scientific FS完全的
-
AbbVie完全的克罗恩病 | 溃疡性结肠炎 (UC)美国, 德国, 以色列
-
Centre Hospitalier Henri LaboritPoitiers University Hospital; Association Francaise pour la Recherche Thermale; Les thermes de... 和其他合作者完全的
-
Barts & The London NHS TrustBristol Royal Infirmary; Institute of Child Health完全的
-
University of OklahomaMassachusetts General Hospital完全的
-
The First Affiliated Hospital with Nanjing Medical...The Second Hospital of Hebei Medical University; The First Affiliated Hospital of Soochow University 和其他合作者完全的
-
Nanyang Technological UniversityMinistry of Education, Singapore完全的
-
Astellas Pharma Global Development, Inc.Pfizer完全的
-
Janssen Research & Development, LLC完全的
-
University Hospital, Basel, SwitzerlandBoston Scientific Corporation完全的
-
Australia New Zealand Gynaecological Oncology GroupBeiGene撤销
-
Daiichi Sankyo Co., Ltd.完全的
-
Daiichi Sankyo, Inc.完全的
-
Clementia Pharmaceuticals Inc.完全的